Skip to content

Effectiveness of a diabetes self-management programme on self-efficacy, self-management behaviours, glycaemic control and diabetes-related distress in people with type 2 diabetes receiving insulin injection: A randomised controlled trial

Effectiveness of a diabetes self-management programme on self-efficacy, self-management behaviours, glycaemic control and diabetes-related distress in people with type 2 diabetes receiving insulin injection: A randomised controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046342
Enrollment
Unknown
Registered
2021-05-14
Start date
2021-06-07
Completion date
Unknown
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Intervention group:A diabetes self-management programme
Control group:Attentional control

Sponsors

The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Chinese people aged 18 years old or above; 2. a medical diagnosis of T2D for at least six months to allow for the development of self-care skills and initial psychological adjustment; 3. receiving insulin injection with or without oral antihyperglycemic agents; 4. a HbA1c test >7.0% within three months of recruitment indicating poor glycaemic control; 5. residing in the communities in Shanghai; 6. available for telephone follow-up; 7. consent to participate in the study; 8. able to communicate in Putonghua and read simplified Chinese.

Exclusion criteria

Exclusion criteria: 1.Participants will be excluded if they have participated in diabetes education programmes within the last six months; cognitive impairment or a major psychiatric disorder (i.e. schizophrenia, bipolar disorder) and currently receiving treatment as indicated by the medical record; 2.severe complications of chronic diseases (i.e. advanced macro-micro vascular complication); 3.severe medical or health conditions (i.e. being bedridden, end-stage renal disease on dialysis, heart failure); 4.terminal illness such as advanced cancer; or aural and/or visual impairment.

Design outcomes

Primary

MeasureTime frame
Self-efficacy;

Secondary

MeasureTime frame
Self-management behaviours;HbA1c;Diabetes-related distress;

Countries

China

Contacts

Public ContactLIANG Wei

The Chinese University of Hong Kong

lovenursing@126.com+852 52273500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026